PT - JOURNAL ARTICLE AU - Berenstein, A TI - E-059 Bleomycin Sclerotherapy for Eyelid Venous Malformations as an Alternative to Surgery or Laser Therapy AID - 10.1136/neurintsurg-2016-012589.131 DP - 2016 Jul 01 TA - Journal of NeuroInterventional Surgery PG - A74--A74 VI - 8 IP - Suppl 1 4099 - http://jnis.bmj.com/content/8/Suppl_1/A74.2.short 4100 - http://jnis.bmj.com/content/8/Suppl_1/A74.2.full SO - J NeuroIntervent Surg2016 Jul 01; 8 AB - Purpose To describe the use of bleomycin in a foam preparation and or radiopaque, and or undiluted in slow flow venous malformations that involve the mucosa of the eyelid, and periorbital area.Material and methods 11 patients with venous malformations, involving the mucosa of the eyelid, and periorbital area, were treated with various combination bleomycin injections in to the lesion under direct puncture, and monitored with US and/or DSA. We will describe the various techniques and when best to use them.Results There was significant improvement, or near total resolution in all patients with a follow up of up to 4 years, there were 2 recurrences, there were no complicationsConclusions The use of bleomycin in various forms appears as a simple, safe and very effective treatment for venous malformations involving the mucosa of the eyelid, and periorbital area, avoiding more elaborated and challenging surgical or laser interventions, and is effective in thicker lesions.Disclosures A. Berenstein: None.